BIVAL 160/12.5 MG BOX OF 30

Treatment of essential arterial hypertension in adults. BIVAL, a fixed-dose combination, is indicated in patients whose blood pressure is not adequately controlled by valsartan or hydrochlorothiazide given as monotherapy.

Description

Speciality BIVAL
Strength 160 mg / 12.5 mg
Pharmaceutical Form Film-coated tablet
Presentation Box of 30
Primary Packaging Blister
Specification ALU/ALU
INN Hydrochlorothiazide, Valsartan
VEIC Classification Essential
Therapeutic Class CARDIOVASCULAR SYSTEM
Subclass AGENTS ACTING ON THE RENIN–ANGIOTENSIN SYSTEM
Laboratory PHILADELPHIA PHARMA
Schedule A
Shelf Life 24 months
Generic/Brand Generic
MA (Marketing Authorization)
MA Date
Range Cardio-Metabolic

Reviews

There are no reviews yet.

Be the first to review “BIVAL 160/12.5 MG BOX OF 30”

Your email address will not be published. Required fields are marked *